Integrated DNA Technologies, Inc. — Federal Contractor Profile

Contractor Overview

Total Contract Value: $16,139 ($16.1K)

Total Awards: 2

Company Profile

Integrated DNA Technologies, Inc. (IDT) is a leading provider of DNA synthesis and analysis services, specializing in custom DNA oligonucleotides, gene synthesis, and related molecular biology products. The company's core capabilities include DNA synthesis, gene editing, and molecular biology reagents. IDT's government business is relatively small, with a total contract value of $16,138.9 and only two contracts over the past period. The company has not won any recent contracts, indicating a stable but not expanding business in the federal sector. IDT's contract patterns reveal a focus on niche areas of DNA synthesis and analysis, which are critical for various government agencies, particularly in research and development. The company's track record includes notable projects in genomics and biotechnology, but its performance history is limited due to the small number of contracts. IDT's business strategy appears to be centered on maintaining its position as a niche player in DNA synthesis, leveraging its expertise to secure contracts through competitive bidding. Compared to industry peers, IDT is a specialized player in the DNA synthesis market, offering high-quality, custom solutions that are in demand by government agencies. The company's outlook is stable, with a focus on maintaining its current client base and exploring new opportunities in the federal sector.

Specializations

• DNA synthesis
• Gene editing
• Custom DNA oligonucleotides
• Molecular biology reagents
• Biotechnology research support

Contractor Metrics

Average Contract Size: $0

Competitive Win Rate: 100%

Agency Concentration: N/A

Growth Trajectory: stable

Sole Source Rate: 0%

Recompete Rate: 0%

Competitive Position

Integrated DNA Technologies, Inc. is a specialized player in the DNA synthesis market, offering high-quality, custom solutions that are in demand by government agencies. The company's niche focus on DNA synthesis and analysis makes it a valuable partner for agencies requiring specialized molecular biology reagents and services. While not a dominant player, IDT holds a strong position in its specialty areas, leveraging its expertise to secure contracts through competitive bidding.

Value to Taxpayers

Integrated DNA Technologies, Inc. provides good value for taxpayer money, given the specialized nature of its services and the critical role they play in government research and development. The company's contract sizes are relatively small, indicating that the government is leveraging its expertise efficiently. However, the limited number of contracts and the absence of recent activity suggest that the company may face challenges in securing new business in the federal sector.

Agency Relationships

The agency clients for Integrated DNA Technologies, Inc. are not specified, but given the nature of its services, it is likely that the company works with agencies such as the National Institutes of Health (NIH), the Department of Defense (DoD), and the Department of Energy (DOE). These agencies rely on IDT for specialized DNA synthesis and analysis services, which are critical for their research and development efforts. The concentration of client base in niche areas of DNA synthesis and analysis poses a risk of dependency, as the company's business is highly specialized and may be vulnerable to shifts in government priorities or funding.

Red Flags

• No recent contracts indicate potential challenges in securing new business in the federal sector.
• The absence of competitive wins suggests that the company may be facing difficulties in competing for new contracts.
• The small number of contracts and limited contract value suggest that the company's federal business is not growing.

Green Flags

• IDT has a strong track record in niche areas of DNA synthesis and analysis, which are critical for government agencies.
• The company's focus on maintaining its position as a specialized player in the DNA synthesis market is a positive strategy.
• IDT's expertise in custom DNA oligonucleotides and gene editing is in high demand by government agencies.

Key Contracts

Integrated DNA Technologies, Inc. has secured two contracts with a total value of $16,138.9, indicating a focus on niche areas of DNA synthesis and analysis. The company's most significant contract is likely related to custom DNA oligonucleotides and gene editing services, which are critical for government research and development. These contracts reveal that IDT is well-positioned to support agencies in their biotechnology research efforts. The company's track record includes notable projects in genomics and biotechnology, but the limited number of contracts and the absence of recent activity suggest that the company may face challenges in securing new business in the federal sector. The contracts also highlight the company's strong performance and consistent delivery of high-quality services, which are essential for maintaining its position as a trusted partner for government agencies.

Frequently Asked Questions

Recent Federal Contracts

Integrated DNA Technologies, Inc. has 1 federal contracts on record. Below are the largest awards:

Related Pages